乙型肝炎肝硬化并发自发性细菌性腹膜炎患者血清白蛋白和肝纤维化指标的变化

doi:10.3969/j.issn.1672-5069.2017.03.027

Abstract

Liu Yuling, Feng Zhenqing, Jia Qiulong, et al.. Changes of serum liver fibrosis index in patients with hepatitis B-induced liver cirrhosis complicated by spontaneous bacterial peritonitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 356-357.

References

[1] 包剑锋,张思泉,刘华锋,等. 肝硬化患者自发性肠球菌性腹膜炎的相关因素分析及病原学特征. 国际流行病学传染病学杂志,2011, 38(6):371-374.
[2] Schmid SA,Wiest R,Salzberger B,et al.Spontan bakterielle peritonitis. Med Klin Intensiv Med Notfmed,2012,107(7):548-552.
[3] 李向春. 乙型肝炎肝硬化并发自发性细菌性腹膜炎临床观察. 世界中医药,2015,12(A2):1512-1513.
[4] 高锦孝,高慧,刘燕,等. 肝硬化患者血清HA、LN、PCⅢ、Ⅳ-C水平的研究及临床意义的探讨. 标记免疫分析与临床,2013,20(4):261-262.
[5] Guevara M,Terra C,Nazar A,et al.Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized,controlled study. J Hepatol,2012,57(57):759-765.
[6] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89.
[7] 于乐成. 美国肝脏研究协会成人患者肝硬化腹水处理实践指南2012修订版. 肝脏,2013,18(9):629-630.
[8] 李健,马晓菊,樊和斌,等. 肝硬化并发继发性腹膜炎10例临床分析. 胃肠病学和肝病学杂志,2011,20(7):662-663.
[9] 李智,周全胜,樊和斌,等. 肝硬化并发SBP腹水病原菌及药物敏感性分析. 现代中西医结合杂志,2011,20(3):289-290.
[10] Lutz P,Parcina M,Bekeredjianding I,et al.Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. Plos One,2014,9(4):42037-42050.
[11] Szczerbinska BK,Stomka M,Celinski K,et al.Prevalence of spontaneous bacterial peritonitis in asymptomatic inpatients with decompensated liver cirrhosis-a pilot study. Adv Med Sci,2011,56(1):13-17.
[12] 居朝霞,陈菊娣,周美芳,等. 腹腔置管灌洗治疗肝硬化自发性细菌性腹膜炎疗效观察. 实用肝脏病杂志,2016,19(4):261-263.
[13] Gupta N,Kim J,Njei B.Spontaneous bacterial peritonitis and henoch-schonlein purpura in a patient with liver cirrhosis. Case Rep Med,2014,15(8):416-419.
[14] 占国清,谭华炳,李芳,等. 肝硬化发生自发性细菌性腹膜炎的危险因素分析. 实用肝脏病杂志,2011,14(5):349-350.
[15] 姚朝光. 哌拉西林/他唑巴坦治疗肝硬化合并SBP的临床观察. 中华医院感染学杂志,2013,23(3):657-659.
[16] Hwang S Y,Yu S J,Lee J H,et al.Spontaneous fungal peritonitis:a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis,2014,33(2):259-264.
[17] 魏兆勇,张分明,李松柏,等. 慢性肝病合并自发性细菌性腹膜炎20例误诊分析. 临床误诊误治,2011,24(1):65-66.
[18] Enomoto H,Inoue S,Matsuhisa A,et al.Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an “unidentified” pathogen. Int J Hepatol,2013,2014(3):634617-634618.
[19] 费琰,倪晓蓉,邹美银. 肝硬化腹水并发自发性细菌性腹膜炎的危险因素分析. 中华实验和临床感染病杂志电子版,2014,8(5):7-10.
[20] 林莺,林琼. 肝硬化合并自发性细菌性腹膜炎的相关因素及预见性护理作用. 包头医学,2015,39(3):155-156.
[21] 黄雪,刘传苗,赵守松等. 失代偿期肝硬化患者SAAG、PA、PTA水平与肝功能分期及预后的关系. 世界华人消化杂志,2016,9(5):790-795.
[22] 贾晓娟,许泽清,韩军,等. 慢性乙型肝炎患者血清HA、PⅢ、CⅣ、LN含量与肝纤维化程度关系的探讨. 中国医药指南,2013,14(12):28-29.

Changes of serum liver fibrosis index in patients with hepatitis B-induced liver cirrhosis complicated by spontaneous bacterial peritonitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.